I. Introduction
Bronchial Asthma and COPD are airway disorders and form a major part of the Physician workload. Both the diseases present as airway obstruction producing wheeze. Though Pulmonary Function Test and other modalities of investigation are available to help us differentiating between these two airway disorders , they may not be available always and everywhere. Hence the need for a test that is useful, less expensive and reproducible one, which helps to differentiate between Asthma and COPD.The Study conducted at Chengalpattu.Medical college and Hospital In the period of January 2015 to November 2015 study group consist of fifty patient each Bronchial asthma, COPD and control.
II. Aim 1.To assess the validity of Sputum Eosinophil count in the diagnosis of Asthma.
2.
To know if the Sputum Eosinophil count can be utilized in differentiation of Bronchial Asthma from COPD.
III. Methods And Materials.
Three groups of patients were selected. 1. Bronchial asthmatics -subjected to PFT pre and post bronchodilator ; patients having a reversibility of > 20% were selected. 2. COPD -subjected to PFT pre and post bronchodilator ; patients with reversibility < 20% and h/o smoking were included. 3. Controls -patients with cough < 2wks with h/o no wheeze , with a normal PFT were selected as Controls. All the patients were subjected to the following investigations. Blood total, differential count Blood eosinophil count Chest Xray Sputum culture and sensitivity Sputum eosinophil percentage. Exclusion criteria; 1. Sputum AFB positive 2. Sputum culture positive 3. CXR Old PT Sequalae Sputum by spontaneous cough or by induced cough with nebulized normal saline were collected in containers; they were smeared on glass slides and eosin, hematoxylin staining was done. Stained slides were handed over to the Pathologist for sputum eosinophil study; he was not revealed about the identity of the slides. Salivary contamination was determined using percentage of squamous cells among nucleated cells. If squamous cells were >10% of nucleated cells, then salivary contamination was high and the slide was discarded. 100 nucleated cells were counted and the percentage of eosinophils among them was calculated. High power and oil immersion fields were utilized for the study.
IV. Results
Sputum eosinophil percentage of > 3% was taken as positive result and less than that as negative result. X2 53.77 P value 0.001 Sputum eosinophil percentage in asthma and controls X2 6.73 P value 0.009 Sputum eosinophil percentage in asthma and COPD X2 11.95 ; P value 0.01 Significant P values shows that sputum eosinophil count can be taken up for differentiating Bronchial asthma and COPD ; and can be used in diagnosis of Asthma. The 95% confidence interval levels of sputum eosinophil count in Asthmatics is 61.83% -86.94%; For COPD it is 28.195 -56.79% infers that it is a significant test in Asthmatics than in COPD.
Age :

V. Discussion
Huster et al compared the validity of different tests in adult asthmatics and found that methacholine airwayresponsiveness and a sputum differential, eosinophil test are useful tests in asthma. Ruth Greene et al 1 had discussed about the usefulness of sputum eosinophil count in the management of Asthma. Bouwmik etal 2 study did not show any difference between induced cough and spontaneous cough sputum samples.
In COPD aptients 40% of people showed sputum eosinophil >3%. Brightling etal 3 showed that sputum eosinophils in COPD suggests steroid responsiveness. Rosi etal 4 states that sputum eosinophils has a good diagnostic accuracy in differentiating asthma fro non asthma. Rhonchi etal 4 says that sputum eosinophil predominate in asthma than in COPD where neutrophils predominate.
VI. Conclusion
1 sputum eosinophil percentage >3% can be used as one of the tools in diagnosis of asthma. 2. it can be used to differentiate from COPD.
